Pomerantz Appointed Lead Counsel in Aclaris Therapeutics Securities Litigation
On November 6, 2019, Pomerantz LLP was appointed lead counsel in a securities litigation class action lawsuit against Aclaris Therapeutics, Inc.
On November 6, 2019, Pomerantz LLP was appointed lead counsel in a securities litigation class action lawsuit against Aclaris Therapeutics, Inc.